Thoracic Surgery (Cardiothoracic Vascular Surgery)

Thoracic Surgery (Cardiothoracic Vascular Surgery)
Audio Summaries

The literature in thoracic surgery (cardiothoracic vascular surgery) doesn't slow down, and the papers you skip might be the ones that change your practice. OSLR turns the journals you'd read if you had the time into 3-minute audio summaries. Listen on your commute, between cases, whenever.

5 active journals958 audio summaries

Journals in Thoracic Surgery (Cardiothoracic Vascular Surgery)

Active journals with audio summaries available on OSLR.

Recent summaries

The latest articles summarized from thoracic surgery (cardiothoracic vascular surgery) journals.

Reproductive health in women in Britain from 2010 to 2024: findings from repeated, cross-sectional National Surveys of Sexual Attitudes and Lifestyles (Natsal).

Lancet (London, England)|Nov 19, 2026

This study compares reproductive health indicators among women aged 16-54 in Britain using nationally representative Natsal surveys from 2010-2012 (Natsal-3) and 2022-2024 (Natsal-4), asking whether reproductive autonomy has improved and how it varies across social groups. Key findings include an increase in lifetime abortion (16.0% to 20.7%), a rise in women aged 16-44 reporting they definitely do not want children (7.7% to 16.6%), and a sharp drop in hormonal contraception use among women under 35. Persistent gaps remain: 18.5% of women at risk of unintended pregnancy reported no effective contraception, and women with lower education, greater deprivation, or Black African/Caribbean/Black British ethnicity faced higher risks of no effective contraception and abortion.

Spontaneous coronary artery dissection: implications for women's health, clinical care, and future research.

Lancet (London, England)|Nov 19, 2026

Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndromes, mainly affecting younger women, and is likely more common than previously thought. This Review synthesizes current evidence on SCAD's epidemiology, mechanisms (including genetic susceptibility), diagnosis, management, and implications for reproductive and women's health. It also identifies research priorities, since evidence guiding pharmacological and interventional treatment remains scarce, even though most patients heal spontaneously and are best managed conservatively.

Seasonal mass vaccination with R21/Matrix-M against malaria in The Gambia and Burkina Faso: an open-label, cluster-randomised, controlled trial.

Lancet (London, England)|Nov 19, 2026

This cluster-randomised trial asked whether seasonal mass vaccination with the R21/Matrix-M malaria vaccine, given before peak transmission, could reduce malaria infection prevalence and be safe in The Gambia (low-to-moderate transmission) and Burkina Faso (intense seasonal transmission). Across 54 villages, three monthly doses reduced the odds of P. falciparum infection at peak transmission by 70% in The Gambia (aOR 0.30) and by 25% in Burkina Faso (aOR 0.75), with the vaccine judged safe and well tolerated. The authors conclude that seasonal mass vaccination could be an additional malaria control strategy in seasonal transmission settings, though its effect was considerably larger in The Gambia than in Burkina Faso.

Plasma eMTBR-tau as a Biomarker for Chronic Traumatic Encephalopathy Tau Tangle Neuropathology.

JAMA|Nov 19, 2026

This case series of 21 former American football players examined whether plasma endogenously cleaved microtubule-binding region tau (eMTBR-tau) could serve as an in vivo biomarker for chronic traumatic encephalopathy (CTE) tau tangle pathology, which currently can only be confirmed at autopsy. Plasma eMTBR-tau was significantly higher in CTE-positive donors than CTE-negative donors, and highest in high-stage CTE with comorbid Alzheimer disease neuropathologic change, with levels also correlating with neuropathologic tau burden. The authors conclude that plasma eMTBR-tau may be a feasible candidate biomarker for high-stage CTE, though larger validation studies are needed to establish diagnostic accuracy and specificity.

Assessing Multiple Treatment Regimens for Tuberculosis.

The New England journal of medicine|Nov 19, 2026

This phase 2 randomized trial (PARADIGM4TB) asked whether new four-drug regimens containing ganfeborole and/or BTZ-043 could shorten or improve tuberculosis treatment compared with the standard 24-week HRZE regimen, using early sputum culture clearance (log10 time-to-positivity slope) as the primary measure. Two regimens, ganfeborole-bedaquiline-pretomanid-moxifloxacin (BPMG) and BTZ-043-bedaquiline-delamanid-moxifloxacin (BDMT), showed a posterior probability of superiority over HRZE of 0.83 and 0.99, respectively, with acceptable safety profiles to advance to further evaluation. The results were used to select regimens for further study rather than to establish definitive efficacy.

Medical Imaging and Pediatric and Adolescent Brain Tumor Risk.

JAMA|Nov 19, 2026

This retrospective cohort study of about 3.7 million children in six US health systems and Ontario, Canada, asked whether cumulative brain radiation dose from medical imaging is associated with later brain or central nervous system tumors. The authors found a dose-related increase in risk, with hazard ratios rising from 1.12 for under 1 mGy to 3.85 for 150 mGy or more, and stronger associations for aggressive tumor types. They estimated roughly 1 excess brain tumor per 1,266 head CT examinations by age 21, supporting careful justification and dose minimization for pediatric imaging that uses ionizing radiation.

Acute Respiratory Distress Syndrome.

The New England journal of medicine|Nov 18, 2026

This review by Calfee and McAuley summarizes the current understanding of acute respiratory distress syndrome (ARDS), a common cause of acute hypoxemic respiratory failure. It addresses the key management challenges, including treating the underlying trigger, avoiding ventilator-induced lung injury and volume overload, and resolving controversies around supporting nonintubated patients, personalizing positive end-expiratory pressure, using innovative ventilation strategies, and giving glucocorticoids. The authors also highlight whether precision medicine approaches based on biologic, radiographic, or physiologic subphenotypes can improve outcomes.

Natural ligand-based CAR T-cell therapy targeting BCMA and TACI for relapsed or refractory multiple myeloma (TriPRIL): a non-randomised, phase 1, first-in-human trial.

Lancet (London, England)|Nov 17, 2026

This first-in-human phase 1 trial tested TriPRIL, an autologous CAR T-cell therapy that uses an engineered trimeric form of the natural ligand APRIL to simultaneously target BCMA and TACI, aiming to reduce antigen escape in relapsed or refractory multiple myeloma. In 15 infused patients (nine of whom had prior BCMA-directed CAR T therapy), the therapy showed a manageable safety profile, with no dose-limiting toxicities or treatment-related deaths, and cytokine release syndrome was limited to grade 1-2. The recommended phase 2 dose was set at 3.0 × 10^8 cells, supporting further investigation of this dual-targeted, natural ligand-based approach.

Hedgehog Signaling-Dependent Heterochronic Control of Cardiomyocyte Differentiation Establishes Distinct Cardiac Progenitor Fields.

Circulation|Nov 17, 2026

This study asks how the three cardiac progenitor fields (first heart field, second heart field, and juxta-cardiac field) are established at distinct times during embryogenesis, a question relevant to congenital heart disease. Using single-cell atlases, gastrulation-stage imaging, and two Hedgehog loss-of-function mouse models, the authors show that Hedgehog signaling acts non-cell-autonomously to delay cardiac differentiation in the second heart field and juxta-cardiac field, while the first heart field evades this signaling and differentiates rapidly. Partial loss of Hedgehog signaling caused premature cardiac differentiation, and complete loss prevented formation of the second heart field and juxta-cardiac field, suggesting a heterochronic mechanism that could serve as a general model for progenitor field emergence during organogenesis.

Toward a Healthier Future Through Obesity Prevention and Care: The JAMA Summit Report on Obesity.

JAMA|Nov 17, 2026

This JAMA Summit report asks how to reduce the growing burden of obesity, which affects over 1 billion people worldwide and nearly half of U.S. adults. The authors conclude that existing prevention measures have been insufficient and that new effective medications, while promising, cannot solve the problem alone. They call for coordinated, multisector action, including food and school policies, drug evaluation modernization, payment reform, multidisciplinary care models, and efforts to reduce stigma and health inequities.

Start listening to thoracic surgery (cardiothoracic vascular surgery) research

14-day free trial. Pick your journals and go.